25 XP   0   0   10

BCAL Diagnostics Ltd
Buy, Hold or Sell?

Let's analyse BCAL Diagnostics Ltd together

PenkeI guess you are interested in BCAL Diagnostics Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BCAL Diagnostics Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about BCAL Diagnostics Ltd

I send you an email if I find something interesting about BCAL Diagnostics Ltd.

Quick analysis of BCAL Diagnostics Ltd (30 sec.)










What can you expect buying and holding a share of BCAL Diagnostics Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.02
Expected worth in 1 year
A$-0.05
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.07
Return On Investment
-66.8%

For what price can you sell your share?

Current Price per Share
A$0.11
Expected price per share
A$0.09 - A$0.165
How sure are you?
50%

1. Valuation of BCAL Diagnostics Ltd (5 min.)




Live pricePrice per Share (EOD)

A$0.11

Intrinsic Value Per Share

A$-0.43 - A$-0.32

Total Value Per Share

A$-0.40 - A$-0.30

2. Growth of BCAL Diagnostics Ltd (5 min.)




Is BCAL Diagnostics Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$3.3m$6.2m-$2.8m-84.9%

How much money is BCAL Diagnostics Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$3.2m-$2.1m-$1m-33.1%
Net Profit Margin-181.4%-471.1%--

How much money comes from the company's main activities?

3. Financial Health of BCAL Diagnostics Ltd (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#123 / 146

Most Revenue
#124 / 146

Most Profit
#86 / 146

Most Efficient
#123 / 146

What can you expect buying and holding a share of BCAL Diagnostics Ltd? (5 min.)

Welcome investor! BCAL Diagnostics Ltd's management wants to use your money to grow the business. In return you get a share of BCAL Diagnostics Ltd.

What can you expect buying and holding a share of BCAL Diagnostics Ltd?

First you should know what it really means to hold a share of BCAL Diagnostics Ltd. And how you can make/lose money.

Speculation

The Price per Share of BCAL Diagnostics Ltd is A$0.105. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of BCAL Diagnostics Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in BCAL Diagnostics Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.02. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of BCAL Diagnostics Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-12.4%-0.01-12.4%-0.01-8.3%-0.01-5.4%0.00-4.7%
Usd Book Value Change Per Share-0.01-10.8%-0.01-10.8%0.0214.7%0.002.6%0.002.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-10.8%-0.01-10.8%0.0214.7%0.002.6%0.002.1%
Usd Price Per Share0.04-0.04-0.08-0.02-0.02-
Price to Earnings Ratio-2.99--2.99--9.32--2.46--2.05-
Price-to-Total Gains Ratio-3.42--3.42-5.23-0.90-0.90-
Price to Book Ratio2.90-2.90-3.27-1.23-1.03-
Price-to-Total Gains Ratio-3.42--3.42-5.23-0.90-0.90-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.067956
Number of shares14715
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (14715 shares)-167.0739.98
Gains per Year (14715 shares)-668.30159.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-668-6780160150
20-1337-13460320310
30-2005-20140480470
40-2673-26820640630
50-3341-33500800790
60-4010-40180960950
70-4678-4686011191110
80-5346-5354012791270
90-6015-6022014391430
100-6683-6690015991590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.03.00.050.0%3.03.00.050.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.06.00.0%0.00.06.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%3.03.00.050.0%3.03.00.050.0%

Fundamentals of BCAL Diagnostics Ltd

About BCAL Diagnostics Ltd

BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

Fundamental data was last updated by Penke on 2024-03-30 05:04:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of BCAL Diagnostics Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit BCAL Diagnostics Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -181.4% means that $-1.81 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BCAL Diagnostics Ltd:

  • The MRQ is -181.4%. The company is making a huge loss. -2
  • The TTM is -181.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-181.4%TTM-181.4%0.0%
TTM-181.4%YOY-471.1%+289.7%
TTM-181.4%5Y-306.5%+125.1%
5Y-306.5%10Y-287.7%-18.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-181.4%-7.2%-174.2%
TTM-181.4%-6.3%-175.1%
YOY-471.1%1.3%-472.4%
5Y-306.5%-3.1%-303.4%
10Y-287.7%-1.4%-286.3%
1.1.2. Return on Assets

Shows how efficient BCAL Diagnostics Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • -60.5% Return on Assets means that BCAL Diagnostics Ltd generated $-0.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BCAL Diagnostics Ltd:

  • The MRQ is -60.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -60.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-60.5%TTM-60.5%0.0%
TTM-60.5%YOY-32.0%-28.5%
TTM-60.5%5Y-58.8%-1.7%
5Y-58.8%10Y-62.9%+4.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.5%-1.5%-59.0%
TTM-60.5%-1.2%-59.3%
YOY-32.0%-0.6%-31.4%
5Y-58.8%-0.6%-58.2%
10Y-62.9%-0.9%-62.0%
1.1.3. Return on Equity

Shows how efficient BCAL Diagnostics Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • -97.1% Return on Equity means BCAL Diagnostics Ltd generated $-0.97 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BCAL Diagnostics Ltd:

  • The MRQ is -97.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -97.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-97.1%TTM-97.1%0.0%
TTM-97.1%YOY-35.1%-62.0%
TTM-97.1%5Y-84.2%-12.8%
5Y-84.2%10Y-70.2%-14.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-97.1%-0.5%-96.6%
TTM-97.1%--97.1%
YOY-35.1%0.3%-35.4%
5Y-84.2%-1.5%-82.7%
10Y-70.2%-2.5%-67.7%

1.2. Operating Efficiency of BCAL Diagnostics Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient BCAL Diagnostics Ltd is operating .

  • Measures how much profit BCAL Diagnostics Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • An Operating Margin of -283.0% means the company generated $-2.83  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BCAL Diagnostics Ltd:

  • The MRQ is -283.0%. The company is operating very inefficient. -2
  • The TTM is -283.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-283.0%TTM-283.0%0.0%
TTM-283.0%YOY-571.1%+288.0%
TTM-283.0%5Y-323.4%+40.4%
5Y-323.4%10Y-301.5%-22.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-283.0%-5.2%-277.8%
TTM-283.0%-3.8%-279.2%
YOY-571.1%4.4%-575.5%
5Y-323.4%1.6%-325.0%
10Y-301.5%-2.0%-299.5%
1.2.2. Operating Ratio

Measures how efficient BCAL Diagnostics Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.87 means that the operating costs are $2.87 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BCAL Diagnostics Ltd:

  • The MRQ is 2.871. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.871. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.871TTM2.8710.000
TTM2.871YOY5.739-2.868
TTM2.8715Y3.547-0.676
5Y3.54710Y2.956+0.591
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8711.302+1.569
TTM2.8711.303+1.568
YOY5.7391.236+4.503
5Y3.5471.254+2.293
10Y2.9561.238+1.718

1.3. Liquidity of BCAL Diagnostics Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if BCAL Diagnostics Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 2.74 means the company has $2.74 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BCAL Diagnostics Ltd:

  • The MRQ is 2.743. The company is able to pay all its short-term debts. +1
  • The TTM is 2.743. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.743TTM2.7430.000
TTM2.743YOY11.000-8.258
TTM2.7435Y8.408-5.665
5Y8.40810Y7.664+0.744
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7432.248+0.495
TTM2.7432.426+0.317
YOY11.0002.753+8.247
5Y8.4082.989+5.419
10Y7.6643.000+4.664
1.3.2. Quick Ratio

Measures if BCAL Diagnostics Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.40 means the company can pay off $1.40 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BCAL Diagnostics Ltd:

  • The MRQ is 1.405. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.405. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.405TTM1.4050.000
TTM1.405YOY14.293-12.889
TTM1.4055Y8.659-7.254
5Y8.65910Y7.873+0.786
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4051.284+0.121
TTM1.4051.357+0.048
YOY14.2931.563+12.730
5Y8.6591.952+6.707
10Y7.8732.127+5.746

1.4. Solvency of BCAL Diagnostics Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of BCAL Diagnostics Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare BCAL Diagnostics Ltd to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.38 means that BCAL Diagnostics Ltd assets are financed with 37.7% credit (debt) and the remaining percentage (100% - 37.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BCAL Diagnostics Ltd:

  • The MRQ is 0.377. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.377. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.377TTM0.3770.000
TTM0.377YOY0.090+0.287
TTM0.3775Y0.231+0.146
5Y0.23110Y0.384-0.153
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3770.425-0.048
TTM0.3770.411-0.034
YOY0.0900.393-0.303
5Y0.2310.450-0.219
10Y0.3840.448-0.064
1.4.2. Debt to Equity Ratio

Measures if BCAL Diagnostics Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 60.6% means that company has $0.61 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BCAL Diagnostics Ltd:

  • The MRQ is 0.606. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.606. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.606TTM0.6060.000
TTM0.606YOY0.099+0.507
TTM0.6065Y0.365+0.241
5Y0.36510Y0.304+0.061
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6060.6060.000
TTM0.6060.571+0.035
YOY0.0990.606-0.507
5Y0.3650.637-0.272
10Y0.3040.730-0.426

2. Market Valuation of BCAL Diagnostics Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings BCAL Diagnostics Ltd generates.

  • Above 15 is considered overpriced but always compare BCAL Diagnostics Ltd to the Diagnostics & Research industry mean.
  • A PE ratio of -2.99 means the investor is paying $-2.99 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BCAL Diagnostics Ltd:

  • The EOD is -5.234. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.991. Based on the earnings, the company is expensive. -2
  • The TTM is -2.991. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.234MRQ-2.991-2.243
MRQ-2.991TTM-2.9910.000
TTM-2.991YOY-9.315+6.325
TTM-2.9915Y-2.461-0.529
5Y-2.46110Y-2.051-0.410
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-5.234-0.202-5.032
MRQ-2.991-0.402-2.589
TTM-2.991-0.119-2.872
YOY-9.315-0.003-9.312
5Y-2.4611.941-4.402
10Y-2.0515.487-7.538
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BCAL Diagnostics Ltd:

  • The EOD is -4.132. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.361. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.361. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.132MRQ-2.361-1.771
MRQ-2.361TTM-2.3610.000
TTM-2.361YOY-4.353+1.991
TTM-2.3615Y-1.343-1.019
5Y-1.34310Y-1.119-0.224
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-4.132-0.179-3.953
MRQ-2.361-0.417-1.944
TTM-2.361-1.057-1.304
YOY-4.353-1.918-2.435
5Y-1.343-2.492+1.149
10Y-1.119-2.398+1.279
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of BCAL Diagnostics Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.90 means the investor is paying $2.90 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BCAL Diagnostics Ltd:

  • The EOD is 5.081. Based on the equity, the company is overpriced. -1
  • The MRQ is 2.903. Based on the equity, the company is underpriced. +1
  • The TTM is 2.903. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD5.081MRQ2.903+2.178
MRQ2.903TTM2.9030.000
TTM2.903YOY3.272-0.368
TTM2.9035Y1.235+1.668
5Y1.23510Y1.029+0.206
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD5.0811.910+3.171
MRQ2.9032.459+0.444
TTM2.9032.236+0.667
YOY3.2723.239+0.033
5Y1.2353.450-2.215
10Y1.0294.118-3.089
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BCAL Diagnostics Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.018-0.0180%0.024-173%0.004-518%0.003-609%
Book Value Per Share--0.0210.0210%0.038-46%0.015+34%0.013+62%
Current Ratio--2.7432.7430%11.000-75%8.408-67%7.664-64%
Debt To Asset Ratio--0.3770.3770%0.090+320%0.231+63%0.384-2%
Debt To Equity Ratio--0.6060.6060%0.099+514%0.365+66%0.304+99%
Dividend Per Share----0%-0%-0%-0%
Eps---0.020-0.0200%-0.013-33%-0.009-56%-0.008-62%
Free Cash Flow Per Share---0.025-0.0250%-0.029+13%-0.013-50%-0.011-57%
Free Cash Flow To Equity Per Share---0.025-0.0250%0.009-396%-0.001-96%-0.001-97%
Gross Profit Margin--1.0381.0380%1.0390%1.015+2%1.013+3%
Intrinsic Value_10Y_max---0.319--------
Intrinsic Value_10Y_min---0.425--------
Intrinsic Value_1Y_max---0.017--------
Intrinsic Value_1Y_min---0.026--------
Intrinsic Value_3Y_max---0.062--------
Intrinsic Value_3Y_min---0.092--------
Intrinsic Value_5Y_max---0.122--------
Intrinsic Value_5Y_min---0.175--------
Market Cap26490975.840+43%15137700.48015137700.4800%31536876.000-52%9334915.296+62%7779096.080+95%
Net Profit Margin---1.814-1.8140%-4.711+160%-3.065+69%-2.877+59%
Operating Margin---2.830-2.8300%-5.711+102%-3.234+14%-3.015+7%
Operating Ratio--2.8712.8710%5.739-50%3.547-19%2.956-3%
Pb Ratio5.081+43%2.9032.9030%3.272-11%1.235+135%1.029+182%
Pe Ratio-5.234-75%-2.991-2.9910%-9.315+211%-2.461-18%-2.051-31%
Price Per Share0.105+43%0.0600.0600%0.125-52%0.037+62%0.031+95%
Price To Free Cash Flow Ratio-4.132-75%-2.361-2.3610%-4.353+84%-1.343-43%-1.119-53%
Price To Total Gains Ratio-5.985-75%-3.420-3.4200%5.227-165%0.904-478%0.904-478%
Quick Ratio--1.4051.4050%14.293-90%8.659-84%7.873-82%
Return On Assets---0.605-0.6050%-0.320-47%-0.588-3%-0.629+4%
Return On Equity---0.971-0.9710%-0.351-64%-0.842-13%-0.702-28%
Total Gains Per Share---0.018-0.0180%0.024-173%0.004-518%0.003-609%
Usd Book Value--3374348.7083374348.7080%6238904.448-46%2509527.967+34%2082445.498+62%
Usd Book Value Change Per Share---0.011-0.0110%0.015-173%0.003-518%0.002-609%
Usd Book Value Per Share--0.0130.0130%0.025-46%0.010+34%0.008+62%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.013-0.0130%-0.009-33%-0.006-56%-0.005-62%
Usd Free Cash Flow---4148915.726-4148915.7260%-4689017.070+13%-2079305.391-50%-1785052.999-57%
Usd Free Cash Flow Per Share---0.016-0.0160%-0.019+13%-0.008-50%-0.007-57%
Usd Free Cash Flow To Equity Per Share---0.016-0.0160%0.006-396%-0.001-96%0.000-97%
Usd Market Cap17144959.564+43%9797119.7519797119.7510%20410666.147-52%6041557.180+62%5034630.983+95%
Usd Price Per Share0.068+43%0.0390.0390%0.081-52%0.024+62%0.020+95%
Usd Profit---3275967.836-3275967.8360%-2191091.070-33%-1436594.759-56%-1247603.988-62%
Usd Revenue--1806037.4881806037.4880%465123.224+288%580192.795+211%509506.043+254%
Usd Total Gains Per Share---0.011-0.0110%0.015-173%0.003-518%0.002-609%
 EOD+5 -3MRQTTM+0 -0YOY+9 -255Y+13 -2110Y+15 -19

3.2. Fundamental Score

Let's check the fundamental score of BCAL Diagnostics Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.234
Price to Book Ratio (EOD)Between0-15.081
Net Profit Margin (MRQ)Greater than0-1.814
Operating Margin (MRQ)Greater than0-2.830
Quick Ratio (MRQ)Greater than11.405
Current Ratio (MRQ)Greater than12.743
Debt to Asset Ratio (MRQ)Less than10.377
Debt to Equity Ratio (MRQ)Less than10.606
Return on Equity (MRQ)Greater than0.15-0.971
Return on Assets (MRQ)Greater than0.05-0.605
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of BCAL Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.105
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets8,371
Total Liabilities3,157
Total Stockholder Equity5,214
 As reported
Total Liabilities 3,157
Total Stockholder Equity+ 5,214
Total Assets = 8,371

Assets

Total Assets8,371
Total Current Assets6,200
Long-term Assets2,171
Total Current Assets
Cash And Cash Equivalents 3,174
Net Receivables 1
Inventory 3,025
Other Current Assets 0
Total Current Assets  (as reported)6,200
Total Current Assets  (calculated)6,200
+/-0
Long-term Assets
Property Plant Equipment 2,171
Long-term Assets  (as reported)2,171
Long-term Assets  (calculated)2,171
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,261
Long-term Liabilities897
Total Stockholder Equity5,214
Total Current Liabilities
Short-term Debt 165
Accounts payable 1,581
Other Current Liabilities 515
Total Current Liabilities  (as reported)2,261
Total Current Liabilities  (calculated)2,261
+/-0
Long-term Liabilities
Long term Debt Total 897
Other Liabilities 0
Long-term Liabilities  (as reported)897
Long-term Liabilities  (calculated)897
+/-0
Total Stockholder Equity
Common Stock19,282
Retained Earnings -14,615
Other Stockholders Equity 547
Total Stockholder Equity (as reported)5,214
Total Stockholder Equity (calculated)5,214
+/-0
Other
Capital Stock19,282
Cash and Short Term Investments 3,174
Common Stock Shares Outstanding 210,903
Liabilities and Stockholders Equity 8,371
Net Debt -2,113
Net Invested Capital 5,214
Net Tangible Assets 5,214
Net Working Capital 3,940
Property Plant and Equipment Gross 2,226
Short Long Term Debt Total 1,061



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
> Total Assets 
560
540
820
4,132
10,590
8,371
8,37110,5904,132820540560
   > Total Current Assets 
559
536
820
4,129
10,455
6,200
6,20010,4554,129820536559
       Cash And Cash Equivalents 
309
277
416
3,408
5,571
3,174
3,1745,5713,408416277309
       Short-term Investments 
0
0
0
0
4,000
0
04,0000000
       Net Receivables 
250
259
403
353
13
1
113353403259250
       Other Current Assets 
0
0
0
368
90
0
090368000
   > Long-term Assets 
0
0
0
4
135
2,171
2,1711354000
       Property Plant Equipment 
0
4
0
4
135
2,171
2,1711354040
> Total Liabilities 
642
52
381
526
950
3,157
3,15795052638152642
   > Total Current Liabilities 
142
52
81
526
950
2,261
2,2619505268152142
       Short-term Debt 
0
0
0
0
0
165
16500000
       Accounts payable 
78
2
60
251
277
1,581
1,58127725160278
       Other Current Liabilities 
27
29
21
275
673
515
515673275212927
   > Long-term Liabilities 
0
0
300
0
0
897
8970030000
       Long term Debt Total 
500
0
300
0
0
897
897003000500
       Other Liabilities 
0
0
0
0
0
0
000000
> Total Stockholder Equity
-82
488
439
3,607
9,640
5,214
5,2149,6403,607439488-82
   Common Stock
3,435
4,435
4,940
9,456
18,872
19,282
19,28218,8729,4564,9404,4353,435
   Retained Earnings -14,615-9,553-6,168-4,643-3,946-3,516
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
0
0
142
318
321
547
54732131814200



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue2,791
Cost of Revenue-114
Gross Profit-1142,677
 
Operating Income (+$)
Gross Profit-114
Operating Expense-7,898
Operating Income-7,898-8,012
 
Operating Expense (+$)
Research Development3,235
Selling General Administrative2,350
Selling And Marketing Expenses195
Operating Expense7,8985,779
 
Net Interest Income (+$)
Interest Income46
Interest Expense-16
Other Finance Cost-16
Net Interest Income46
 
Pretax Income (+$)
Operating Income-7,898
Net Interest Income46
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,062-10,689
EBIT - interestExpense = -7,914
-5,108
-5,046
Interest Expense16
Earnings Before Interest and Taxes (EBIT)-7,898-5,046
Earnings Before Interest and Taxes (EBITDA)-7,785
 
After tax Income (+$)
Income Before Tax-5,062
Tax Provision-0
Net Income From Continuing Ops-5,062-5,062
Net Income-5,062
Net Income Applicable To Common Shares-5,062
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,898
Total Other Income/Expenses Net2,791-46
 

Technical Analysis of BCAL Diagnostics Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of BCAL Diagnostics Ltd. The general trend of BCAL Diagnostics Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine BCAL Diagnostics Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BCAL Diagnostics Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.125 < 0.145 < 0.165.

The bearish price targets are: 0.092 > 0.09 > 0.09.

Tweet this
BCAL Diagnostics Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BCAL Diagnostics Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BCAL Diagnostics Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Moving Average Convergence/Divergence (MACD) ChartBCAL Diagnostics Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BCAL Diagnostics Ltd. The current adx is .

BCAL Diagnostics Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Relative Strength Index (RSI) ChartBCAL Diagnostics Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Stochastic Oscillator ChartBCAL Diagnostics Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Commodity Channel Index (CCI) ChartBCAL Diagnostics Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Chande Momentum Oscillator (CMO) ChartBCAL Diagnostics Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Williams %R ChartBCAL Diagnostics Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Average True Range (ATR) ChartBCAL Diagnostics Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily On-Balance Volume (OBV) ChartBCAL Diagnostics Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BCAL Diagnostics Ltd.

BCAL Diagnostics Ltd Daily Money Flow Index (MFI) ChartBCAL Diagnostics Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BCAL Diagnostics Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

BCAL Diagnostics Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BCAL Diagnostics Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.105
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of BCAL Diagnostics Ltd with someone you think should read this too:
  • Are you bullish or bearish on BCAL Diagnostics Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about BCAL Diagnostics Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BCAL Diagnostics Ltd

I send you an email if I find something interesting about BCAL Diagnostics Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about BCAL Diagnostics Ltd.

Receive notifications about BCAL Diagnostics Ltd in your mailbox!